Filing Details
- Accession Number:
- 0001179110-12-012841
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-14 16:01:24
- Reporting Period:
- 2012-08-10
- Filing Date:
- 2012-08-14
- Accepted Time:
- 2012-08-14 16:01:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1277478 | Glenn Sblendorio | 8 Sylvan Way Parsippany NJ 07054 | President & Cfo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-08-10 | 8,989 | $25.09 | 96,877 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-08-10 | 25,000 | $17.45 | 121,877 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-08-10 | 25,000 | $25.15 | 96,877 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option(right to buy) | Disposition | 2012-08-10 | 25,000 | $0.00 | 25,000 | $17.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 65,000 | 2021-02-18 | No | 4 | M | Direct |
Footnotes
- The range of prices for the transactions reported on this line is between $25.01 and $25.21 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The range of prices for the transactions reported on this line is between $25.10 and $25.23 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- As of 8/10/2012, the original grant (90,000 shares granted on 2/18/2011) was vested with respect to 31,875 of the shares covered thereby and the remaining 58,125 shares covered by this option vest in equal monthly installments ending on 2/18/2015. After the exercise of the options reported hereby, as of 8/10/2012, 6,875 of the shares covered by the option were vested but not exercised.
Billionaire Hedge Funds
